Q32 Bio Inc banner

Q32 Bio Inc
LSE:0T6G

Watchlist Manager
Q32 Bio Inc Logo
Q32 Bio Inc
LSE:0T6G
Watchlist
Price: 6.49 USD 6.48% Market Closed
Market Cap: $79.8m

Wall Street
Price Targets

0T6G Price Targets Summary
Q32 Bio Inc

Wall Street analysts forecast 0T6G stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0T6G is 14.67 USD with a low forecast of 9.68 USD and a high forecast of 20.13 USD.

Lowest
Price Target
9.68 USD
49% Upside
Average
Price Target
14.67 USD
126% Upside
Highest
Price Target
20.13 USD
210% Upside
Q32 Bio Inc Competitors:
Price Targets
AFYA
Afya Ltd
13% Upside
SHLS
Shoals Technologies Group Inc
45% Upside

Revenue
Forecast

N/A
Past Growth
-77% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
-77% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Q32 Bio Inc's revenue for the next 3 years is -77%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0T6G's stock price target?
Price Target
14.67 USD

According to Wall Street analysts, the average 1-year price target for 0T6G is 14.67 USD with a low forecast of 9.68 USD and a high forecast of 20.13 USD.

What is Q32 Bio Inc's Revenue forecast?
Projected CAGR
-77%

The compound annual growth rate of Q32 Bio Inc's revenue for the next 3 years is -77%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett